Polypharmacy is often associated with older adults and people living with several chronic diseases, but it can occur whenever multiple conditions, symptoms or treatment guidelines converge. A patient may receive separate medicines for hypertension, diabetes, pain, infection or gastrointestinal symptoms, while different clinicians may prescribe without a complete view of the person’s current regimen. Some combinations are medically necessary and can improve survival or disease control. The concern arises when medicines are duplicated, continued after their original indication has disappeared, prescribed without adequate monitoring, or used in combinations whose benefits do not outweigh their risks. The biological challenge is cumulative: each medicine can produce intended effects as well as side effects, and one drug may alter the absorption, metabolism or elimination of another. As the number of medicines rises, the possible interaction pathways multiply, making careful medication reconciliation and periodic review increasingly important.

The Nigerian research used two complementary approaches. First, the investigators retrospectively examined 2,000 prescriptions issued between January and June 2025 to estimate how frequently patients were receiving multiple medicines. They then conducted a prospective questionnaire survey from July through August involving 100 patients and 50 healthcare providers. The prescription review provided a numerical snapshot of prescribing patterns, while the questionnaires explored the financial consequences for patients and the perceptions of professionals working in the hospital. This design allowed the team to connect prescribing complexity with reported affordability problems, although it cannot establish that polypharmacy itself caused patients to reduce their medicines. The study was cross-sectional in its survey component, meaning that it captured experiences over a defined period rather than tracking patients over time to determine whether medication changes led to later complications or hospital visits.

Of the prescriptions examined, 63 percent contained two to four medicines, a range the researchers classified as non-polypharmacy for the purposes of the study. Another 25 percent contained five to nine medicines, described as major polypharmacy, while 12 percent contained at least 10 medicines, categorized as excessive polypharmacy. Taken together, the latter two groups accounted for 37 percent of all prescriptions. These figures do not necessarily mean that 37 percent of patients were receiving inappropriate treatment. A prescription containing several medicines may be clinically justified, particularly for patients with multiple chronic conditions or acute illness. The study instead identifies the scale of medication exposure and the need to determine whether each medicine remains necessary, effective and affordable. Without detailed diagnoses, treatment indications and clinical outcomes for every prescription, the data cannot distinguish appropriate combination therapy from potentially avoidable prescribing.

The financial findings were especially striking. Among the 100 patients who completed questionnaires, 37 percent reported spending more than 20,000 Nigerian naira per month on medicines. The researchers did not convert that amount into a universal international comparison, because the real impact depends on household income, local prices and other living costs, but the responses show that medication expenditure was not a marginal concern. Seventy-nine percent of participants described drug costs as a financial burden, and 78 percent said they needed financial assistance to obtain the medicines prescribed for them. In a predominantly out-of-pocket healthcare environment, the price of each additional product can become a barrier to completing treatment. Patients may borrow money, rely on relatives, purchase only part of a prescription or substitute medicines without professional guidance, creating a cycle in which the intended therapeutic plan is never fully implemented.

The researchers found that 66 percent of surveyed patients had skipped doses or reduced their medicines because of cost. This behavior, known as cost-related nonadherence, can undermine treatment even when the prescription is pharmacologically sound. For medicines used to control blood pressure or blood glucose, intermittent dosing may produce unstable disease control rather than a simple reduction in benefit. For antimicrobial treatment, taking medicines inconsistently can fail to clear an infection, although the relationship between adherence and antimicrobial resistance is complex and depends on the drug, pathogen and treatment regimen. Reducing or skipping medicines can also make clinicians interpret uncontrolled symptoms as evidence that a treatment is ineffective, potentially prompting additional prescriptions and increasing polypharmacy further. The result is a dangerous feedback loop: more medicines raise costs, high costs reduce adherence, and poor adherence may lead to even more intensive treatment.

Healthcare providers surveyed in the study recognized the same pattern from the clinical side. Eighty-four percent said they frequently encountered patients taking five or more medicines, and every provider agreed that polypharmacy significantly increases treatment costs. Clinicians may face genuine pressure to address several problems during a single consultation, particularly in facilities serving communities with limited access to specialist care. Prescribing can also be shaped by fragmented records, limited consultation time, patient expectations and the availability of medicines. A complete medication review requires more than asking whether a patient is taking tablets. It involves identifying every prescription, over-the-counter product, traditional remedy and supplement; checking dose, duration, indication and duplication; considering kidney and liver function; and evaluating whether the patient can follow the schedule. Pharmacists, physicians and nurses can work together to simplify regimens, select lower-cost equivalents when appropriate and stop medicines whose risks exceed their benefits.

The study’s implications extend beyond one hospital. Nigeria, like many low- and middle-income countries, must manage rising burdens of chronic disease while healthcare financing remains uneven. As people live longer and survive illnesses that once would have been fatal, the number of patients requiring long-term treatment is likely to grow. At the same time, medicine prices, transport costs and shortages can place therapy beyond reach. Expanding health insurance coverage could reduce the direct financial shock of multiple prescriptions, but insurance alone would not solve inappropriate or unnecessarily complex treatment. The authors point to rational prescribing and strengthened medication-review practices as parallel solutions. Rational prescribing means selecting a medicine that matches a clearly defined clinical need, at the correct dose and duration, while considering safety, effectiveness, affordability and the patient’s ability to use it. Electronic prescribing systems and shared records could help, but even paper-based review protocols may identify duplication and unnecessary continuation.

The findings should nevertheless be interpreted with care. The study was conducted in a single secondary healthcare facility, so its prescribing patterns may not represent hospitals elsewhere in Nigeria or other healthcare levels. The patient survey included only 100 participants, and information about spending, skipped doses and financial assistance was self-reported, which can introduce recall or reporting bias. The researchers also measured the number of medicines rather than documenting adverse drug reactions, hospital admissions, disease outcomes or the clinical appropriateness of each combination. Further research across multiple facilities could examine which diseases and prescribing departments contribute most to polypharmacy, how much of the medication burden is clinically justified, and whether pharmacist-led reviews reduce costs without harming health outcomes. Even with these limitations, the central signal is clear: when 37 percent of prescriptions contain five or more medicines and most surveyed patients struggle to pay for them, medication management becomes both a safety issue and an economic one. The challenge is not merely to prescribe fewer drugs, but to ensure that every medicine a patient receives has a defensible purpose, a measurable benefit and a realistic path to completion.

Blood pressure management is crucial for reducing the risk of severe complications, such as cardiovascular diseases and stroke, in elderly patients. This cohort often faces unique challenges, including polypharmacy, cognitive decline, and varying levels of health literacy, making the effective management of hypertension a complex endeavor. The study delves into how self-management strategies can positively influence blood pressure control amongst this vulnerable group.

A closer examination of the study’s methodology reveals an innovative use of latent class analysis. This statistical technique allows researchers to identify unobserved subgroups within a population, facilitating a deeper understanding of patient behaviors. By categorizing patients based on their self-management habits, the researchers can pinpoint which behaviors most significantly impact blood pressure levels. This information is invaluable for tailoring personalized treatment plans and interventions.

The research team conducted a comprehensive survey among elderly patients with hypertension, assessing their practices related to blood pressure monitoring, medication adherence, dietary adjustments, and lifestyle changes. Through rigorous data analysis, they successfully categorized participants into distinct groups, each with varying degrees of blood pressure control correlated to their self-management behaviors. The findings indicate a clear relationship: those who actively engaged in self-monitoring and adapted their lifestyles demonstrated better blood pressure outcomes.

Moreover, the study highlights the importance of education and awareness in managing hypertension. Many elderly patients may not fully understand their condition or the implications of uncontrolled blood pressure. By increasing health literacy, the healthcare system could empower patients, equipping them with the knowledge to make informed decisions about their health. This educational aspect is fundamental, as it forms the basis for long-term behavioral change.

Collaborative care models emerge as a focal point in this conversation. The integration of healthcare providers, patients, and caregivers can create a supportive environment that fosters effective self-management. By facilitating communication among these stakeholders, patients may feel more confident in their abilities, thereby enhancing their adherence to treatment recommendations. This approach mirrors contemporary models of chronic disease management, where patient involvement is paramount.

As the demographic shift towards an aging population continues, the implications of this research become even more critical. Hypertension prevalence among older adults is rising, necessitating improved management strategies. The study’s findings emphasize the need for policymakers to invest in programs that promote self-management education and support systems, ensuring that the elderly have access to the resources required for effective hypertension control.

The intersection of technology and self-management also cannot be overlooked. With the advent of telemedicine and health monitoring apps, elderly patients are increasingly able to track their blood pressure and engage with healthcare providers remotely. These tools can promote a proactive approach to health management, allowing individuals to monitor their conditions closely while maintaining independence. The potential for technology to facilitate behavioral change is an exciting avenue for future research.

In addition to the behavioral aspects, the emotional and psychological components of living with hypertension deserve attention. Anxiety and depression are common comorbidities in patients with chronic health issues, including hypertension. Addressing mental health alongside physical health can enhance overall well-being and improve management outcomes. The study encourages a holistic approach, taking into consideration not only what patients do but how they feel about their health and self-management practices.

Furthermore, the research indicates that social support plays a pivotal role in successful self-management. Family and community support can significantly impact the motivation and ability of elderly patients to adhere to treatment plans. Strengthening these social networks may boost patients’ confidence, encourage routine health check-ups, and ultimately, lead to better health outcomes. This highlights the importance of community engagement in healthcare frameworks.

While the study sheds light on effective self-management behaviors, it also opens the door for future investigations. There remain many questions regarding the long-term sustainability of these behaviors and how they evolve over time. Understanding the factors that influence adherence could lead to the development of interventions that help patients maintain their self-management practices throughout the course of their lives.

In conclusion, the findings from Liu et al. provide a compelling narrative about the association between blood pressure control and self-management among elderly patients with hypertension. By harnessing the knowledge gained from this research, there is potential to enhance the quality of care for aging populations, ultimately improving their health outcomes. The study stands as a testament to the complex interplay between behavior, education, and healthcare, underlining the importance of a multifaceted approach to managing chronic conditions like hypertension.

As we move forward, it is essential for healthcare providers, policymakers, and communities to work collaboratively to create an environment that supports effective self-management behaviors among the elderly. Only through such concerted efforts can we hope to tackle the growing challenge of hypertension in an aging society, enabling our elderly population to lead healthier, more fulfilling lives.

Subject of Research: Self-management behaviors and blood pressure control in elderly patients with hypertension.

Article Title: The association between blood pressure control and multiple self-management behaviors in elderly patients with hypertension: a study based on latent class analysis.

Article References: Liu, M., Zhang, T., Guo, W. et al. The association between blood pressure control and multiple self-management behaviors in elderly patients with hypertension: a study based on latent class analysis. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-07131-4

Image Credits: AI Generated

DOI: 10.1186/s12877-026-07131-4

Keywords: hypertension, elder patients, self-management behaviors, blood pressure control, latent class analysis, healthcare, chronic disease management.

Polypharmacy is prevalent among older adults, often due to the management of multiple chronic conditions. This accumulation of drugs can lead to adverse drug events, increased hospitalizations, and various complications. Consequently, the approach of deprescribing—meaning the systematic reduction of medications—has gained traction. However, navigating this complex landscape requires a skilled approach, particularly when considering the nuances of each patient’s health status, medications, and overall quality of life.

The study’s design is noteworthy: it was an implementation study with a retrospective control group, allowing the researchers to compare the outcomes of patients who underwent the pharmacist-led deprescribing intervention against those who did not receive such specialized care. The study’s focus on both effectiveness and implementation makes it a valuable contribution to the literature on best practices in medication management for older adults.

Pharmacists often possess extensive knowledge about pharmacology and the potential interactions between different medications. By engaging pharmacists in the deprescribing process, healthcare teams can leverage this expertise to ensure that patients only continue medications that are truly beneficial, while safely discontinuing those that pose more risks than rewards. The findings in this study suggest that involving pharmacists in medication reviews for older inpatients leads to significant improvements in health outcomes.

Detailed analysis revealed that a substantial proportion of patients experienced a decrease in the number of medications prescribed after participating in the deprescribing intervention. This not only reduced the burden of daily medication regimens but also contributed to improvements in patient-reported outcomes such as quality of life. Additionally, the researchers found that patients experienced fewer adverse drug events, thus underscoring the safety aspect of the intervention.

Moreover, the implementation study sheds light on the collaborative dynamics within healthcare teams. The success of the pharmacist-led approach is significantly impacted by effective communication and teamwork among healthcare providers. This is particularly crucial in a hospital setting, where multidisciplinary teams must collaborate to optimize patient care. The study showed that when pharmacists actively participated in rounds and discussions about medication management, they could influence treatment decisions positively.

Nevertheless, the researchers acknowledged several challenges within the study. One of the significant barriers identified was the sometimes entrenched habits of prescribers who may be resistant to making changes to long-standing medication regimens. Additionally, institutional protocols and workflows sometimes lacked the flexibility needed to accommodate a pharmacist’s input in a timely manner.

Despite these hurdles, the findings are compelling. The study concluded that implementing pharmacist-led deprescribing protocols not only enhances patient safety but also streamlines medication management processes. This could have downstream effects on hospital resource utilization and healthcare costs, as reducing unnecessary medications can potentially decrease the number of adverse drug events requiring additional medical attention.

As healthcare continues to evolve, studying the efficacy of various interventions, like those led by pharmacists, provides valuable insights into improving patient care and outcomes. The evidence supporting pharmacist-led initiatives will likely catalyze changes in policies and practices in hospitals across the globe, fostering a more holistic approach to managing the complexities of medication therapy for older adults.

Furthermore, as the healthcare landscape adapts to advances in technology and shifts toward value-based care, the role of pharmacists is poised for expansion. Their clinical expertise in pharmacotherapy, coupled with a focus on patient-centered care, positions them as key players in ensuring that patients receive optimal and safe medication management.

As healthcare providers, policymakers, and researchers reflect on the implications of this study, they must consider how to integrate such pharmacist-led initiatives into broader strategies aimed at improving geriatric care. Ultimately, initiatives that enhance the quality of life for older adults while minimizing adverse effects of medications should be prioritized.

Maintaining the health and well-being of an aging population is a complex challenge that requires innovative solutions. This research undoubtedly adds a significant piece to the puzzle of effective medication management, providing a model that other healthcare systems might emulate. As we look to the future, it is imperative to remain committed to exploring and implementing evidence-based approaches to ensure the best outcomes for our elders.

The findings from this implementation study, slated for publication in the European Geriatric Medicine journal, will likely provoke discussions and debates among healthcare professionals regarding best practices and the evolving landscape of medication management. As healthcare continues to focus on multidisciplinary approaches, the integration of pharmacists into patient care pathways will undoubtedly set a precedent for future interventions aimed at enhancing patient safety and efficacy in medication therapy.

In conclusion, the impact of these findings transcends the specific context of the study and taps into a broader narrative about the importance of interdisciplinary healthcare teams. By maximizing the role of pharmacists within these teams, there exists a significant opportunity to transform the healthcare experience for older adults. The study’s results emphasize the need for ongoing research, education, and advocacy aimed at refining medication practices to cater to the unique needs of this population.

Subject of Research: Pharmacist-led deprescribing intervention in older inpatients.

Article Title: Effectiveness of a pharmacist-led deprescribing intervention in older inpatients: an implementation study with retrospective control group.

Article References:

Dearing, M., Bowles, S.K., Isenor, J.E. et al. Effectiveness of a pharmacist-led deprescribing intervention in older inpatients: an implementation study with retrospective control group.
Eur Geriatr Med (2026). https://doi.org/10.1007/s41999-025-01371-0

Image Credits: AI Generated

DOI: 29 January 2026

Keywords: Deprescribing, Pharmacist-led intervention, Older adults, Polypharmacy, Medication management.

Polypharmacy, defined as the simultaneous use of multiple medications by a patient, has been a growing concern, especially among the elderly who often suffer from multiple chronic conditions. This phenomenon poses several risks, including adverse drug interactions, increased side effects, and the potential for diminished quality of life. Older adults with LEP represent a particularly vulnerable subgroup, as language barriers can complicate medication adherence and healthcare communication, leading to a range of undesired health outcomes.

The landscape of healthcare in the United States is rapidly evolving, with the demographic of older adults becoming increasingly diverse. According to the U.S. Census Bureau, by 2030, nearly one in five Americans will be of retirement age, and many will belong to racial and ethnic minority groups. This age group is already dealing with complex health issues, and when combined with language barriers, the risks associated with polypharmacy can worsen significantly.

The study employs a comprehensive approach, leveraging data from numerous health surveys and patient interviews to quantify the prevalence of polypharmacy among older adults with LEP. Researchers utilized robust statistical methods to ensure the accuracy of their findings while addressing potential confounding variables. The results indicate that older adults with LEP are more likely to be prescribed multiple medications compared to their English-speaking counterparts.

One of the key findings of the research is the intersection of polypharmacy and inadequate healthcare access. Many older adults with LEP often face challenges in accessing healthcare services, which can lead to inconsistent medication management. Disparities in healthcare access pave the way for an increased likelihood of polypharmacy, as these individuals may not receive proper medication counseling or follow-up care. Hence, the need for linguistically and culturally sensitive healthcare practices has never been more urgent.

Furthermore, the implications of polypharmacy extend beyond the individual level; they can also impact public health systems. Increased hospitalization rates due to medication-related complications among older adults with LEP can burden healthcare resources. Emergency departments often see a spike in cases involving adverse drug events, where communication breakdowns may have played a role. This cascading effect underscores the necessity for healthcare policymakers to prioritize strategies aimed at mitigating polypharmacy within this population.

Healthcare providers must be equipped with the tools and resources necessary to evaluate and address polypharmacy effectively. Enhancing communication with patients who have LEP is essential, and this can be achieved through a variety of strategies, including employing multilingual staff, providing translated materials, and utilizing technology-driven solutions such as telehealth services. The integration of interpreters can also play a pivotal role in ensuring that medical consultations are thorough and that patients understand their treatment plans.

Engaging family members or caregivers of older adults with LEP can also enhance medication management. Often, these individuals act as vital conduits of support, helping to ensure that medications are taken as prescribed. Building a supportive network that includes family, caregivers, and healthcare providers can lead to better health outcomes for older adults facing the complexities of polypharmacy.

The long-term consequences of unaddressed polypharmacy among older adults with LEP could compound existing health disparities. As the population ages and becomes more diverse, it is crucial to remain vigilant in recognizing and addressing the specific needs of this group. The study serves as a critical reminder that language accessibility is not merely a matter of convenience but a fundamental aspect of equitable healthcare.

To combat polypharmacy among older adults with LEP, community-based interventions should be developed and tested. These could include educational programs aimed at empowering patients to discuss their medications openly and effectively with their healthcare providers. Involving community organizations that work with LEP populations can also be a powerful strategy in changing the narrative around medication use and adherence.

Moreover, the role of technology in addressing polypharmacy cannot be overstated. Advances in health information technology can facilitate better tracking of prescriptions and flag potential drug interactions. Mobile health applications designed for older adults can also serve as reminders for medication adherence, while ensuring that language preferences are taken into account, ultimately leading to higher engagement and compliance rates.

As the US grapples with an increasingly aging and diverse population, the health disparities laid bare by this study remind us of the critical need for continued research and advocacy. Interventions must be tailored not only to the medical needs of older adults but also to the social determinants that impact their health. By elevating the voices of those who are often marginalized in healthcare discussions, we can aim to construct a more equitable health system for future generations.

In conclusion, the study by Wan, Ramachandran, Muir, and their team highlights an urgent and growing public health issue. As we look ahead, it is essential that the challenges posed by polypharmacy and healthcare disparities among older adults with LEP are met with innovative strategies, genuine compassion, and commitment from all sectors of society. Only then can we hope to achieve a healthcare landscape that meets the needs of our increasingly diverse aging population.

Subject of Research: Polypharmacy among older adults with limited English proficiency in the United States.
Article Title: Polypharmacy Among US Older Adults with Limited English Proficiency: 2013–2018.
Article References:

Wan, Y., Ramachandran, R., Muir, K.J. et al. Polypharmacy Among US Older Adults with Limited English Proficiency: 2013–2018.
J GEN INTERN MED (2026). https://doi.org/10.1007/s11606-026-10228-6

Image Credits: AI Generated
DOI: https://doi.org/10.1007/s11606-026-10228-6
Keywords: Polypharmacy, limited English proficiency, older adults, healthcare disparities, medication management.

Frail older adults often have multiple comorbidities, polypharmacy, and varying degrees of functional impairment. These factors contribute to the complexity of prescribing anticoagulants safely and effectively. The findings from the DOAC-FRAIL questionnaire survey provide vital insights that healthcare professionals can leverage to improve clinical practices. The voices of these professionals highlight a myriad of factors influencing their decision-making processes, extending beyond simple clinical guidelines to encompass patient-centered considerations.

One of the striking elements revealed by the study is the recognition of individual patient characteristics that must be taken into account when prescribing DOACs. Providers express a growing awareness of the variability in treatment tolerability and efficacy across different subsets of older adults. Attentiveness to renal function, history of falls, and cognitive status emerges as pivotal factors that can sway prescribing decisions. This acknowledgment emphasizes that a one-size-fits-all approach is insufficient; rather, prescribers must tailor their strategies to the unique needs of each patient.

The survey’s results demonstrate an overarching concern regarding the lack of comprehensive guidelines specifically addressing frail elders. Despite a wealth of research focusing on the effectiveness of DOACs in the general population, the nuanced specter of frailty presents a challenge for prescribers. The authors suggest that more robust clinical guidelines are essential to fill this gap, allowing healthcare professionals to navigate the complexities with greater confidence.

Another significant takeaway from the study is the ongoing education required to ensure healthcare professionals are adequately trained in the subtleties of prescribing for frail older patients. Many prescribers report feeling uncertain about the appropriate use of DOACs, especially in the context of varying clinical scenarios that may arise in this diverse population. This finding accentuates the importance of continuous medical education and collaborative learning environments that engage healthcare providers in discussions about best practices.

The DOAC-FRAIL questionnaire not only captures the perspectives of prescribers but also emphasizes the importance of interprofessional collaboration. The study stresses the value of involving pharmacists and geriatric specialists in the prescribing process to enhance safety and efficacy. A multi-disciplinary approach can provide a holistic view of the patient’s health, ensuring that all aspects of their well-being are taken into account when considering anticoagulation therapy.

Moreover, the hesitance to prescribe DOACs for frail patients may also stem from concerns about the potential for adverse events. The integration of shared decision-making into clinical practice highlights how vital it is for healthcare providers to engage patients in discussions surrounding their treatment options. This dialogue can alleviate concerns and foster a collaborative environment, where patients feel empowered to voice their preferences and fears regarding anticoagulation therapy.

As public and healthcare systems increasingly prioritize patient safety, the implications of prescribing DOACs to frail older adults become even more critical. The potential for major complications, such as bleeding risks, must be carefully weighed against the benefits of anticoagulation, particularly when treating patients with a history of stroke or atrial fibrillation. The survey findings serve as a reminder that ongoing risk assessments are essential in monitoring patients throughout their treatment journey.

In light of increasing frailty among the aging population, tailoring anticoagulation strategies for older adults is no longer a matter of choice but of necessity. The survey results emphasize the immediate need for research to further understand the pharmacokinetics and pharmacodynamics of DOACs in this group. By leveraging existing data while encouraging innovative studies, researchers can help optimize treatment protocols.

The exploration of healthcare professionals’ perspectives through the DOAC-FRAIL questionnaire not only highlights existing gaps in knowledge but also calls for interdisciplinary discussions to shape future studies. By harnessing insights from multiple stakeholders, including physicians, nurses, and allied health professionals, a more comprehensive understanding of frailty and anticoagulation can emerge—ripe for implementation in clinical environments.

With the growing burden of frailty in older adults, healthcare systems worldwide face the pressing challenge of adapting their practices. This adaptability requires the integration of a patient-centered approach, aiming for not just clinical efficacy but also improved quality of life for patients. The findings from the DOAC-FRAIL questionnaire can therefore serve as a catalyst for enhancing standards of care and fostering innovative solutions in anticoagulation therapy.

As aging demographics continue to shift, the dialogue surrounding frail older patients and their treatment remains critical. This study reinforces the value of capturing the perspectives of healthcare professionals in order to develop more informed clinical guidelines and practices. Achieving excellence in patient care for frail older patients would benefit significantly from an ongoing commitment to research and education aimed at refining anticoagulation strategies.

In conclusion, the urgent need to address frailty in elderly populations calls for a profound understanding of the complexities surrounding DOAC prescriptions. The insights shared through the DOAC-FRAIL questionnaire provide a foundation for building a safer, more effective framework for delivering anticoagulation therapy to frail older patients, ultimately improving their health outcomes and overall quality of life. Continued research, education, and collaborative practice are essential in paving the way forward in geriatric medicine.

Subject of Research: Healthcare professionals’ perspectives on prescribing DOACs to frail older patients.

Article Title: Healthcare professionals’ perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire.

Article References:

de Jong, M., Brys, A.D., Braeken, D. et al. Healthcare professionals’ perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire.
BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-06972-3

Image Credits: AI Generated

DOI: 10.1186/s12877-026-06972-3

Keywords: DOACs, frail elderly, anticoagulation therapy, healthcare professionals, patient-centered care, geriatric medicine, clinical practice, shared decision-making.

The study led by Weir, Lüthold, and Rozsnyai meticulously investigates the alignment—or lack thereof—between the decisions made by healthcare providers and the preferences of their elderly patients. One of the most notable findings from the study is the significant lack of concordance in deprescribing efforts. This discordance amplifies the complexity of patient care in cases where older individuals are prescribed multiple medications, often leading to a treatment mismatch that could jeopardize patient safety. The study underscores just how essential it is for general practitioners to engage in collaborative discussions with their patients about ongoing medications, ensuring that both perspectives are taken into account when evaluating therapeutic regimens.

Understanding the rationale behind deprescribing is critical in a medical landscape where overprescribing has become a common dilemma. Healthcare practitioners are often faced with the challenge of balancing the necessity of medications to treat chronic conditions against the potential harms of prolonged therapy. Furthermore, many patients may be hesitant to reduce medications, fearing negative health repercussions. This lack of communication can create a chasm where neither party feels fully informed about the implications of their medication choices, resulting in suboptimal care.

Research conducted in diverse settings has consistently shown that patients often prefer to be involved in decision-making regarding their treatment plans. However, many feel that this is not reflective in their interactions with healthcare professionals. The study highlights that fostering a strong doctor-patient relationship is imperative for effective deprescribing practices. Mutual trust and open communication channels can facilitate these discussions, encouraging an environment where patients feel empowered to voice their concerns and preferences regarding their medication regimens.

The phenomenon of polypharmacy drives the need for effective deprescribing, as older adults frequently find themselves navigating a complicated landscape of medications. Each additional medication increases the risk of drug-drug interactions, side effects, and complications that may worsen a patient’s condition. The findings from the Swiss study reiterate the importance of periodic medication reviews conducted by general practitioners to assess the continued necessity of each drug in a patient’s regimen. Pharmacological vigilance can lead to innovative strategies for selecting interventions that truly enhance the welfare of older adults while minimizing unnecessary risks.

A striking aspect of the research is how it nuances the conversation around patient-centered care. While it primarily examines the gap in understanding between general practitioners and patients, it raises broader questions about systemic barriers that can hinder effective healthcare delivery. For one, the pressure of time-limited consultations often leads to insufficient opportunities for comprehensive discussions involving deprescribing. This is further compounded by the increasing workload facing general practitioners, which can significantly detract from their ability to spend adequate time on shared decision-making with older adults.

Interestingly, the study also delves into the psychological elements influencing deprescribing decisions. Both practitioners and patients harbor psychological biases that may affect their attitudes toward medications. For instance, the fear associated with stopping a medication may be rooted in the assumption that it is essential for health maintenance. Conversely, practitioners may harbor a belief that their clinical judgment supersedes that of their patients. These biases can create significant obstacles in reaching consensus on deprescribing, emphasizing the importance of training healthcare professionals in effective communication skills that prioritize empathy and understanding.

Moreover, the implications of the study extend beyond individual doctor-patient interactions; they highlight the need for institutional change. Training healthcare providers on the principles of geriatric pharmacotherapy and enhancing education around deprescribing can significantly improve outcomes in primary care settings. Such educational initiatives must also include strategies for effective communication, equipping practitioners with the necessary skills to navigate sensitive conversations around medication management.

The discrepancy in deprescribing decisions, as indicated by the study, calls for a paradigm shift in how we approach medical treatment for older adults. With an increasing elderly population facing chronic health challenges, recalibrating the approach toward more collaborative practices could potentially transform the healthcare experience. By fostering an environment of mutual respect and open dialogue, we can bridge the gap in understanding and ultimately achieve more satisfactory healthcare outcomes for older patients.

In summary, the insights from Weir and colleagues reinforce the critical need for integrated, patient-centered approaches to deprescribing practices in Swiss primary care. Breaking down barriers between healthcare providers and patients is essential to ensure that treatment aligns with patients’ needs and preferences. The future of medication management in geriatric care lies in honoring the voices of older adults, valuing their concerns and involving them as active participants in shaping their health care journeys. This proactive engagement could pave the way for more individualized treatment plans that not only prioritize safety but also promote a higher quality of life for the aging population.

Ultimately, the research highlights that the path forward relies on enhancing communication, dismantling existing biases, and fostering collaborative relationships within the healthcare landscape. The study does not merely examine the discrepancies; it serves as a clarion call for practitioners to embark on shared decision-making journeys alongside their patients. In doing so, we can create a healthcare system that is truly representative of the needs and desires of those it aims to serve – leading to a harmonious union of clinical expertise and patient autonomy.

Subject of Research: Deprescribing Decisions in Swiss Primary Care

Article Title: Deprescribing Decisions in Swiss Primary Care: Low Concordance Between General Practitioners and Older Adults.

Article References: Weir, K.R., Lüthold, R.V., Rozsnyai, Z. et al. Deprescribing Decisions in Swiss Primary Care: Low Concordance Between General Practitioners and Older Adults. J GEN INTERN MED (2026). https://doi.org/10.1007/s11606-025-10081-z

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s11606-025-10081-z

Keywords: deprescribing, polypharmacy, primary care, older adults, patient-centered care, medication management

Polypharmacy refers to the concurrent use of multiple medications, often defined as the use of five or more prescription drugs. This phenomenon is increasingly rampant among older adults, primarily due to the complex nature of aging, which often comes with multiple chronic conditions requiring various treatments. While medications can bring therapeutic benefits, the implications of polypharmacy can result in unintended consequences, including drug interactions, increased side effects, and a higher risk of hospitalization. This multifaceted problem has raised alarms among healthcare professionals, policymakers, and families alike.

The study’s authors recognize that older adults are vulnerable to the risks associated with polypharmacy given their unique health profiles. By focusing on this demographic, the research aims to unveil the economic burdens placed on the healthcare system due to inappropriate or excessive prescribing practices. The results of this study could serve as a call to action, urging healthcare providers to reconsider their prescribing behaviors in favor of more streamlined and patient-centered approaches.

Utilizing extensive healthcare databases—integrated with statistical matching techniques—the researchers meticulously paired participants based on their healthcare profiles, controlling for variables such as age, gender, ethnicity, and the presence of comorbidities. This method allowed for a clearer understanding of the direct relationship between the number of medications taken and healthcare expenditures, drawing valuable insights that could potentially influence future healthcare policies and practices.

Among the significant findings, the study reveals that increased medication usage is strongly correlated with heightened healthcare costs. The analysis sheds light on the direct costs related to medication purchase, as well as indirect costs tied to hospital admissions, emergency department visits, and extended healthcare consultations. These economic impacts underscore the need for a reassessment of current prescribing practices, advocating for a more holistic approach to managing chronic conditions amongst older adults.

Another critical insight garnered from this research pertains to the quality of care received by older adults subjected to polypharmacy. It was found that individuals on multiple medications often reported lower health-related quality of life scores. This relationship emphasizes the need to balance the therapeutic benefits of necessary medications against the potential risks associated with treating multiple conditions simultaneously.

With the United States experiencing a growing aging population, the implications of this study cannot be overstated. As older adults represent a significant percentage of healthcare consumers, understanding their unique needs is paramount for the sustainable future of healthcare. The findings advocate for interdisciplinary teams that engage various healthcare professionals in managing older adults’ medications, thereby reducing the burden of polypharmacy and associated healthcare costs.

Furthermore, the potential for personalized medicine in addressing polypharmacy among older adults is highlighted. The promise of genetic testing could enable clinicians to tailor medication regimens, thereby minimizing adverse drug reactions while effectively managing chronic conditions. This forward-thinking approach could revolutionize how polypharmacy is viewed and addressed, paving the way for improved health outcomes and reduced expenditures.

Educating patients and caregivers about the implications of polypharmacy is another avenue that this study brings to light. Empowering older adults with knowledge regarding their medications can foster better decision-making and adherence to prescribed regimens. Moreover, providing families with resources will enable them to engage in meaningful discussions with their healthcare providers regarding the necessity of prescribed medications.

In the context of this research, healthcare providers are encouraged to adopt a more cautious approach to prescribing. By integrating medication reviews into routine care practices, providers can help ensure that older adults are receiving medications that are genuinely necessary for their health and well-being. This cautious approach could also involve deprescribing, where medications that no longer serve a purpose or contribute positively to a patient’s health are safely discontinued.

Ultimately, this study serves a dual purpose: illuminating the challenges posed by polypharmacy among older adults while addressing the resulting financial implications on the healthcare system. By recognizing and addressing these challenges head-on, the research aims to inspire a paradigm shift in how older adults are treated in a healthcare setting, ultimately contributing to more sustainable healthcare practices.

In summary, the intricate relationship between polypharmacy and healthcare expenditures among older adults presents a pressing challenge. The findings of this extensive study not only emphasize the need for a more thoughtful, evidence-based approach to prescribing but also highlight the importance of collaborative care and patient education. As the healthcare landscape continues to evolve, embracing these insights could shift the trajectory towards more effective and economical care for an aging population.

As society gears up to confront the realities of an aging population, the insights from this study pave the way for transformative healthcare solutions, underscoring the critical need for change in managing polypharmacy among older adults. The call to action is clear—prioritizing patient-centered approaches will not only enhance the quality of care but also shape the future of healthcare expenditure in the United States.

Subject of Research: The relationship between polypharmacy and healthcare expenditures among older adults in the United States.

Article Title: Polypharmacy and healthcare expenditures among older adults in the United States: a propensity score-matched study.

Article References:

Pan, S., Li, S., Shi, Y. et al. Polypharmacy and healthcare expenditures among older adults in the United States: a propensity score-matched study.
BMC Geriatr (2025). https://doi.org/10.1186/s12877-025-06545-w

Image Credits: AI Generated

DOI:

Keywords: Polypharmacy, healthcare costs, older adults, medications, healthcare expenditures, chronic conditions, geriatric health.

The study, deriving its data from the IATROPREV initiative, meticulously assesses the medication review practices in older adults at the point of hospital discharge. This demographic, often characterized by polypharmacy – the concurrent use of multiple medications – is at heightened risk of adverse drug events. Such occurrences can lead to preventable complications, unnecessary hospital readmissions, and, ultimately, decreased quality of life.

Researchers, led by Cornille and collaborators, tapped into the wealth of data provided by the IATROPREV study, meticulously analyzing how medication reviews influence the health outcomes of older adults. By focusing on this specific phase of patient care, the researchers sought to fill a significant gap in existing literature, highlighting the critical juncture between inpatient hospitalization and outpatient care.

Key findings indicate that systematic medication reviews can substantially mitigate risks associated with polypharmacy. The exercise involves more than merely cataloging prescriptions; it requires a thorough evaluation of each medication’s purpose, effectiveness, and any potential adverse interactions. The study underscores the importance of tailoring therapeutic regimens to the individual needs of patients, adjusting dosages, and, when necessary, phasing out unnecessary medications that no longer align with a patient’s treatment goals.

Another striking aspect of the research involves the integration of multidisciplinary teams in the medication review process. Collaboration among pharmacists, nurses, and physicians can foster comprehensive care discussions that address the complexities of managing medications for older adults. When healthcare providers share insights on patient histories and ongoing treatments, they are better equipped to propose changes that enhance adherence and safety.

Moreover, the psychological and emotional dimensions of medication adherence were also examined. For many elderly patients, the fear of side effects or misunderstandings about their medications can lead to non-compliance. The findings advocate for better patient education tailored to the unique challenges faced by older adults, emphasizing the importance of clear communication in building trust and understanding regarding their treatment plans.

In addition to exploring the benefits of medication reviews, the researchers provided an analysis of existing barriers that hinder effective implementation. Despite the evidenced benefits, there remains significant variability in how healthcare institutions conduct medication reviews upon discharge. Variances in institutional protocols, clinician training, and resource availability pose challenges that need to be systematically addressed.

With the aging global population continuing to expand, the implications of this research are considerable. As societies grapple with the complexities associated with aging, it becomes crucial to refine discharge processes that not only prioritize physical health but also enhance overall well-being. Ensuring that older adults receive appropriate follow-up care and medication management can significantly impact their long-term health outcomes.

Taking these findings into consideration, healthcare systems are encouraged to adopt evidence-based protocols that standardize medication reviews as part of discharge planning. By doing so, they can bolster patient safety, reduce healthcare costs associated with avoidable readmissions, and ultimately improve the quality of life for older adults.

Looking forward, ongoing research in this area remains necessary. Future studies should aim to explore long-term outcomes associated with enhanced medication review practices, evaluating their effectiveness in diverse populations across different healthcare settings. The ultimate goal is to establish a uniform framework that could transform the landscape of geriatric care.

The researchers have ignited a conversation that underscores the necessity for systemic change in how medication management is approached at discharge. Their work serves as a clarion call to prioritize the safety and well-being of older adults during critical healthcare transitions, an endeavor that must be supported by both healthcare professionals and policymakers alike.

As we move towards a more patient-centered approach in healthcare, the integration of thorough medication reviews into discharge planning stands out as a beacon of hope. With the right frameworks and support systems in place, there is potential for substantial improvements in the health outcomes and quality of life for older adults navigating the complexities of modern medicine.

In conclusion, this pivotal research brings to light the critical need for effective medication reviews in older adults at the point of hospital discharge. As healthcare systems worldwide strive for excellence in patient care, embracing these findings could pave the way for revolutionary improvements in geriatric medicine, making strides towards ensuring safer transitions and more resilient healthcare for our aging population.

Subject of Research: Medication review in older adults at hospital discharge
Article Title: Medication review in older adults at hospital discharge: an analysis of data from the IATROPREV study
Article References:

Cornille, C., Beuscart, JB., Décaudin, B. et al. Medication review in older adults at hospital discharge: an analysis of data from the IATROPREV study.
Eur Geriatr Med (2025). https://doi.org/10.1007/s41999-025-01381-y

Image Credits: AI Generated
DOI: 16 December 2025
Keywords: Medication review, older adults, hospital discharge, polypharmacy, patient safety, IATROPREV study.

Medication errors have become a national concern, significantly affecting the health and safety of patients, particularly older adults. The gravity of this issue is not only indicative of systemic failures within healthcare delivery but also emphasizes the urgent need for improved protocols and practices in discharge planning. The researchers adopted a prospective cohort study design, meticulously tracking older adults through their hospitalization and discharge processes. This systematic approach allowed them to gather rich, qualitative data that could reveal the complexities and nuances of medication management in this sensitive demographic.

The study’s findings revealed that a staggering number of older adults experience medication discrepancies from the moment they transition out of the hospital. These discrepancies can include variations in medication dosages, omissions of critical prescriptions, or misunderstandings regarding the purpose of certain medications. Such oversights not only jeopardize the patients’ health but also increase the likelihood of readmission, which can further exacerbate their medical conditions and lead to additional healthcare costs. Along with these alarming statistics, the research pinpointed specific phases of discharge planning where the potential for error is particularly high.

One significant area of concern identified by the researchers was the inadequate communication between hospital staff and patients during the discharge process. The study highlights a lack of comprehensive discussion regarding medications, with many patients leaving the hospital with little understanding of their medication regimens. Elderly patients often rely on family members or caregivers for support, yet the disconnect between healthcare providers and these support systems can lead to further confusion and mismanagement of medications. The study suggests employing more robust communication strategies with patients and their families to ensure clarity and understanding.

Additionally, the study delves into the often-overlooked role of electronic health records (EHRs) in medication discharge planning. While EHRs have been implemented to improve the accuracy and efficiency of patient data management, the study reveals that they can also serve as a double-edged sword. In many cases, EHRs do not adequately represent the complexity of an older patient’s medication needs, leading to oversimplified medication lists that can mislead healthcare providers. Researchers advocate for a more user-friendly EHR design that takes into account the specific requirements of older adults, allowing for better medication reconciliation during discharge.

In terms of clinical implications, the findings call for stricter protocols and standardized practices to be implemented in hospitals. Systems must be developed to routinely assess the medication management processes in place, ensuring they are effective in preventing errors. This involves training healthcare professionals to recognize the unique challenges presented by older adult patients and equipping them with the skills necessary to navigate these challenges effectively. The study emphasizes that fostering a culture of accountability among healthcare providers can significantly diminish the prevalence of medication errors.

Further substantiating their findings, the research team conducted interviews with both patients and healthcare professionals, gathering first-hand accounts of their experiences with medication discharge planning. These qualitative insights provided a deeper understanding of the emotional and psychological toll medication errors can take on older adults, who may struggle with feelings of helplessness and anxiety regarding their health outcomes. The narratives revealed that individuals are often ill-informed about their medication regimens and lack the confidence to voice concerns or ask questions upon discharge.

The consequences of medication errors extend beyond individual patients; they pose a broader threat to public health systems. The financial burden associated with adverse drug events, readmissions, and prolonged hospital stays is significant and highlights the need for healthcare reform that prioritizes the safety of vulnerable populations. This study, therefore, speaks to the urgent need for policymakers to consider legislative measures that support enhanced discharge planning and medication reconciliation processes.

As the healthcare landscape continues to evolve, researchers stress the importance of interdisciplinary collaborations among healthcare providers. Doctors, nurses, pharmacists, and social workers must work in conjunction to create a seamless discharge experience for older adults. Collaborative practices can help ensure that all teams are informed about the patient’s medication history and the specific challenges they may face post-discharge. The study advocates for more training programs that emphasize interdisciplinary communication and teamwork in discharge planning.

To further enrich the discourse around medication safety, the findings of this study serve as a basis for future research initiatives. Addressing gaps in medication management for older adults is a pressing issue requiring continuous exploration and innovation. Researchers suggest the introduction of pilot programs that focus on testing new discharge planning strategies or technologies aimed at increasing the accuracy of medication reconciliation and enhancing patient education.

Ultimately, the study serves as a clarion call to healthcare systems to take definitive action in tackling the pervasive issue of medication errors among older adults. By acknowledging the complex interplay of various factors that contribute to these errors, stakeholders in the healthcare sector can begin to implement targeted solutions that not only safeguard the health of vulnerable populations but also fortify the integrity of care delivery across hospital systems. In light of the ongoing challenges presented by an aging population, this research underscores the necessity for a dedicated focus on medication safety and discharge planning reforms.

As excitement builds around the potential for innovations that could improve patient outcomes, this study sets a precedent for a proactive approach to preventing medication errors. By sharing their findings widely and advocating for policy changes, researchers hope to drive the conversation forward and ignite a transformation in how medication discharge planning is perceived within the healthcare community. The collective goal is to achieve a significant reduction in medication errors, ultimately enhancing the quality of care and improving the well-being of older adults as they transition from hospital to home.

In conclusion, Anderson and colleagues’ study shines a critical light on an underexplored area of healthcare that warrants immediate attention. Addressing the systemic failures in medication discharge planning for older adults is not merely a matter of improving numbers; it is about respecting the dignity of older patients and ensuring they are afforded the best possible care during one of the most vulnerable times in their lives. As the healthcare landscape advances, it is imperative that we remember the human element at the center of our systems and prioritize their needs above all else.

Subject of Research: Medication Errors and Discharge Planning in Hospitalized Older Adults

Article Title: Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study

Article References:

Anderson, T.S., Wilson, L.M., Wang, B.X. et al. Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study.
J GEN INTERN MED (2025). https://doi.org/10.1007/s11606-025-09973-x

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s11606-025-09973-x

Keywords: Medication errors, discharge planning, older adults, healthcare systems, medication reconciliation, patient safety.